BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 29084078)

  • 41. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of microRNA-155 in inflammatory bowel disease and its clinical significance].
    Ye YL; Pang Z; Gu W; Zheng JJ
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3716-3719. PubMed ID: 29325325
    [No Abstract]   [Full Text] [Related]  

  • 46. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-18 is increased only in a minority of patients with active Crohn's disease.
    Schmidt C; Giese T; Goebel R; Schilling M; Marth T; Ruether A; Schreiber S; Zeuzem S; Meuer SC; Stallmach A
    Int J Colorectal Dis; 2007 Sep; 22(9):1013-20. PubMed ID: 17318554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn's disease and ulcerative colitis.
    Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Krajewska WM; Stec-Michalska K; Piechota-Polańczyk A; Wiśniewska-Jarosińska M; Fichna J
    Scand J Gastroenterol; 2017; 52(6-7):711-715. PubMed ID: 28272905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
    Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
    Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epithelial expression of interleukin-37b in inflammatory bowel disease.
    Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
    Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of MicroRNA-21 in Colonic CD3+ T Cells in UC Remission.
    Ando Y; Mazzurana L; Forkel M; Okazaki K; Aoi M; Schmidt PT; Mjösberg J; Bresso F
    Inflamm Bowel Dis; 2016 Dec; 22(12):2788-2793. PubMed ID: 27824649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease.
    Beltrán CJ; Núñez LE; Díaz-Jiménez D; Farfan N; Candia E; Heine C; López F; González MJ; Quera R; Hermoso MA
    Inflamm Bowel Dis; 2010 Jul; 16(7):1097-107. PubMed ID: 20014018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Bodelier AG; Jonkers D; van den Heuvel T; de Boer E; Hameeteman W; Masclee AA; Pierik MJ
    Dig Dis Sci; 2017 Feb; 62(2):465-472. PubMed ID: 27933473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining.
    Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y
    Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease.
    Omata F; Birkenbach M; Matsuzaki S; Christ AD; Blumberg RS
    Inflamm Bowel Dis; 2001 Aug; 7(3):215-20. PubMed ID: 11515847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
    Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.